Preexposure prophylaxis for HIV infection among African women - Test2 - elhamkhani - TriplyDB

Preexposure prophylaxis for HIV infection among African women

Preexposure prophylaxis for HIV infection among African women

http://www.wikidata.org/entity/Q29620077

about

Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects How do HIV-negative individuals in sub-Saharan Africa change their sexual risk behaviour upon learning their serostatus? A systematic review Beyond the Pap Smear: Gender-responsive HIV Care for Women Biomarkers and biometric measures of adherence to use of ARV-based vaginal rings Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence - a narrative review Protocol for a systematic review: understanding the motivations and barriers to uptake and use of female-initiated, primary biomedical HIV prevention technologies in sub-Saharan Africa How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores"Preparing for HIV pre-exposure prophylaxis: lessons learned from post-exposure prophylaxis A pill for HIV prevention: déjà vu all over again?Preexposure prophylaxis for HIV prevention: where have we been and where are we going?Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges Multipurpose prevention technologies: the future of HIV and STI protection Preventing HIV infection: pre-exposure and postexposure prophylaxis A lifecycle approach to HIV prevention in African women and children Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic review Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches Evidence and AIDS activism: HIV scale-up and the contemporary politics of knowledge in global public health Antiretroviral pharmacology in mucosal tissues Review: [corrected] The changing face of the HIV epidemic in sub-Saharan Africa Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study.Factors Associated with Adherence and Concordance Between Measurement Strategies in an HIV Daily Oral Tenofovir/Emtricitibine as Pre-exposure Prophylaxis (Prep) Clinical Trial, Botswana, 2007-2010.Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission Vaginal challenge with an SIV-based dual reporter system reveals that infection can occur throughout the upper and lower female reproductive tract Profile of cabotegravir and its potential in the treatment and prevention of HIV-1 infection: evidence to date Pre-exposure Prophylaxis for HIV Prevention: Why, What, Who and How Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery Care of the HIV-infected pregnant woman in the developed world Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis Applying a PrEP Continuum of Care for Men Who Have Sex With Men in Atlanta, Georgia Adherence in the CAPRISA 004 tenofovir gel microbicide trial The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies

P2860

Q21144588-7CFC13BC-A4AD-4920-8214-718D59D94416 Q21203732-A9D5E60A-F3DF-4FF6-AC3C-F1E5AC7BF204 Q24201955-D2950E7B-E52A-46D5-9E8D-EA803CD65797 Q24610019-6533DA8C-5243-4544-A399-51167DE67906 Q26741027-65D397C2-E450-4652-94EC-2D05A2F4BE1A Q26746179-FA8D2B6C-69D2-4EAA-B8E0-E5A95CFD1117 Q26753097-1511AB54-780D-4D6D-A0BD-AD4EBA26CAC1 Q26765043-15AD2A95-99F3-4140-B600-D8224B71F274 Q26778293-5A80E974-92F7-48F9-AFCD-A010B544AC51 Q26796724-F1615B88-B028-4C80-B9C9-F1AA5639264A Q26798250-F87B3E3F-F6FB-49E3-8E17-ABD9EDF64BEC Q26820865-66D76B32-226C-421D-9DC4-1BC719F8F802 Q26824606-173B9BF1-F5B3-4043-8715-D85EA857D219 Q26825042-1E4A60BF-F53D-4671-A46A-0E52A175CF6F Q26825641-4A72AAC7-E2D3-4EBC-B68C-CD68FA2C9B7F Q26827796-0399A83F-30C4-46D6-85BF-41254087CAC2 Q26828445-D651E0B8-BD4E-4355-81AD-4DD55E292CBB Q26829308-83A4A7EA-2B52-435D-A0B9-48B75CD52DE6 Q26849762-9C62CE66-2CA1-45A9-8098-8C1EB363C9E3 Q26851448-08B1E894-1899-4AD5-B838-993C1C611B2A Q27005602-38C2746B-81D4-4625-B94D-0D9745800E13 Q27007464-8F09D1E9-E2DA-46F2-AD75-7D78DD9B4BC2 Q27014675-4034E525-ECB2-42C1-A6E0-0E3DBB2BEAB8 Q27022927-9D74B6BC-B43A-437A-A5C9-5CD69A0EC077 Q27023352-67C441A2-1C30-4456-A1C9-D57E42E6070E Q27300707-CCB92846-4679-45E0-86F5-7A749B17CE07 Q27313352-A07D2BE4-02F2-4972-A1E3-B4E73387BADA Q27318158-A8721657-7A48-47AB-9455-979C6095C3CF Q27318354-9AEADE08-9359-4CBF-BD44-F854BB8D4B29 Q27323310-0050A1F6-222B-4D49-893B-97F9756A4AAE Q28079025-1647CE47-8259-4191-854A-295DDBE542A1 Q28080301-B156790E-1EF3-4F57-8E5D-4E43558093F3 Q28081272-EC1C4EA9-FB56-4F45-94E5-3BC448ED2077 Q28082774-A889EE11-7B42-47C1-9053-B9B344E7C19C Q28085433-B65EA86B-AABA-49CE-88F4-48E00880670C Q28088473-3E734164-6A9C-42ED-B95E-FA7ADDD772A9 Q28236148-97C1BE55-9145-44D4-8879-AFFD71BA8FD4 Q28484308-6C91A0F4-E845-4163-BA02-F547DC76D0F3 Q28485356-6F9FB365-E4B7-4143-ADCF-EEEC2799F2CD Q28487926-D966BCBF-842F-4940-8393-60B821CEACA6

P2860

Preexposure prophylaxis for HIV infection among African women

http://www.wikidata.org/entity/Q29620077

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Preexposure prophylaxis for HIV infection among African women

@ast

Preexposure prophylaxis for HIV infection among African women

@en

type

label

Preexposure prophylaxis for HIV infection among African women

@ast

Preexposure prophylaxis for HIV infection among African women

@en

prefLabel

Preexposure prophylaxis for HIV infection among African women

@ast

Preexposure prophylaxis for HIV infection among African women

@en

P1433

Q29620077-F8F1A0E8-2130-4DFF-9AF7-A9804A06F8A0

P1476

Q29620077-72F3CD73-AE48-44BF-B132-2D766E9E6054

P2093

Q29620077-026C3235-1395-47FB-8B6D-A0EB25D35B0B

Q29620077-03F2DDAA-7BE5-42EE-8028-AFA64E62586C

Q29620077-0E297EFC-E776-40DB-905E-169412096E39

Q29620077-0E9EA44F-6CFC-4219-A5D7-7153075793FF

Q29620077-26B6AD8B-B090-4268-A895-B083CC3B5AC0

Q29620077-478F4BA4-0407-479F-9073-FDC409FEC5C3

Q29620077-4C203D57-4CFF-4D01-9238-719DF7754D1A

Q29620077-58891935-6C8A-4DB4-9C72-1BCCF53A65A4

Q29620077-5CA44D42-D830-49EA-9248-FB6AE0C6060D

Q29620077-6175FF5A-0F02-4A59-8B2C-30C7E16F5E85

P2860

Q29620077-2180AE65-B134-4F3F-B945-299ACDE970A0

Q29620077-2DE27746-552F-4042-9041-BC1E2E989F60

Q29620077-75DFCAD6-437F-4089-8C85-E36FD68787A1

Q29620077-A9F5B4A5-5CED-4DF8-9564-6001FD7ADC78

Q29620077-B86FB9F5-9331-458F-9310-A960CEC03751

P304

Q29620077-20A648B3-7FC5-47E7-ABF1-12A6659C608C

P31

Q29620077-A0BBBBC2-99AF-46F0-96DD-23CDDD4FEC45

P3181

Q29620077-AB342E56-9AF8-45D7-953B-F4BE940913EC

P356

Q29620077-92C7FC9D-8998-49D4-9E44-BE3ED070213E

P407

Q29620077-B67FF975-A704-4A14-962B-B9E274D96504

P433

Q29620077-7EE8B530-B2DD-401E-A716-B52A14CCF72D

P478

Q29620077-35B9B3AD-1BC4-48C3-9FFE-1CEB9F0FE316

P50

Q29620077-6F348F35-ACA0-4FE7-B6DC-EEC49B7657C4

P577

Q29620077-9749BF85-542B-4D93-9626-949019D30728

P698

Q29620077-F6CBC7F6-9E0F-4047-8A53-B1630A0D2B8F

P932

Q29620077-FA0525BB-455E-4E0D-B34D-383A08F722F8

P3181

P356

P1433

The New England Journal of Medicine

P1476

Preexposure prophylaxis for HIV infection among African women

@en

P2093

Amy Corneli

http://www.w3.org/2001/XMLSchema#string

Angela Kashuba

http://www.w3.org/2001/XMLSchema#string

Christina Wong

http://www.w3.org/2001/XMLSchema#string

Douglas Taylor

http://www.w3.org/2001/XMLSchema#string

FEM-PrEP Study Group

http://www.w3.org/2001/XMLSchema#string

Fredrick Owino

http://www.w3.org/2001/XMLSchema#string

Haddie Kiernan

http://www.w3.org/2001/XMLSchema#string

Ilse Reblin

http://www.w3.org/2001/XMLSchema#string

Jacob Onyango

http://www.w3.org/2001/XMLSchema#string

Jennifer Deese

http://www.w3.org/2001/XMLSchema#string

P2860

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana

Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission.

Pre-exposure prophylaxis for HIV prevention: how to predict success.

P304

411-422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

585709

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA1202614

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

367

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22784040

http://www.w3.org/2001/XMLSchema#string

P932

3687217

http://www.w3.org/2001/XMLSchema#string